NEUPHORIA THERAPEUTICS INC
NEUP·64136E102·US·Common Stock·Healthcare - Biotechnology-Activist
NEUP (NEUPHORIA THERAPEUTICS INC) is held by 8 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($578,685), GEODE CAPITAL MANAGEMENT, LLC ($211,668), CITADEL ADVISORS LLC ($78,677). Net institutional sentiment: Mixed.
8
Holders
Avg rating(3 Elite)
$925,233
Total Value
67% (11)
Fund Consensus
6 buying - 3 selling
Who's Trading
ActivistBABaselake Partners, LP4.1%Feb 6, 2026
ActivistLYLynx1 Capital Management LP16.3%Dec 29, 2025
ActivistCOCoastlands Capital LP5.1%Nov 5, 2025
ActivistSHShay Capital LLC7.3%Oct 31, 2025
InsiderLLLynx1 Capital Management LPBuy $3.3MOct 21, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer